Emerson Electric
EMR
159.22
-2.18
-1.35%
Emerson Electric
US · EMR
#267 by market cap
Listed 1970
159.22
-2.18
-1.35%
Live - 5344 symbols - heartbeat 52s ago
· 2026-10-08 04:00
Pre-market
159.22
0.00%
After-hours
159.15
-0.04%
Overnight
159.22
0.00%
- Market cap
- 88.81B
- P/E (TTM)i
- 34.84
- P/Bi
- 4.36
- EPSi
- 4.04
- Div yieldi
- 1.38%
- 52W posi
- 85%
Reader sentiment
Are you bullish or bearish on EMR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.49, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.00% YoY
Margins
- Gross margin
- 52.84%
- Operating margin
- 19.60%
- Net margin
- 12.73%
Key ratios & quality
- Enterprise valuei
- 100.52B
- Altman Z-Scorei
- 4.49
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.41B | 18.37B | 16.79B | 12.93B | 13.80B | 15.17B | 17.49B | 18.02B |
| Gross profit | 7.43B | 7.82B | 7.01B | 5.73B | 6.31B | 7.43B | 8.89B | 9.52B |
| Selling & admin expenses | 4.27B | 4.46B | 3.99B | 3.49B | 3.61B | 4.19B | 5.14B | 5.10B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.95B | 3.12B | 2.78B | 1.96B | 2.36B | 2.76B | 2.67B | 3.53B |
| Pretax profit | 2.67B | 2.86B | 2.34B | 1.76B | 2.43B | 2.90B | 2.02B | 2.93B |
| Tax | 443.00M | 531.00M | 345.00M | 346.00M | 549.00M | 642.00M | 415.00M | 696.00M |
| Net profit | 2.22B | 2.33B | 1.99B | 2.33B | 3.23B | 13.20B | 1.96B | 2.25B |
| Basic EPS | 3 | 4 | 3 | 4 | 5 | 23 | 3 | 4 |
| Diluted EPS | 3.46 | 3.71 | 3.24 | 3.82 | 5.41 | 22.88 | 3.43 | 4.04 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.43B | 4.55B | 4.86B | 4.35B | 4.56B | 4.87B |
| Gross profit | 2.37B | 2.39B | 2.52B | 2.31B | 2.42B | 2.66B |
| Selling & admin expenses | 1.28B | 1.27B | 1.33B | 1.24B | 1.32B | 1.34B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 859.00M | 908.00M | 982.00M | 864.00M | 901.00M | 1.11B |
| Pretax profit | 629.00M | 734.00M | 796.00M | 775.00M | 793.00M | 916.00M |
| Tax | 199.00M | 154.00M | 160.00M | 169.00M | 175.00M | 198.00M |
| Net profit | 430.00M | 586.00M | 637.00M | 606.00M | 618.00M | 718.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.86 | 1.04 | 1.12 | 1.07 | 1.10 | 1.28 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 6.62B | 7.14B | 8.81B | 8.43B | 8.51B | 13.82B | 10.19B | 8.58B |
| Cash & ST investments | 1.09B | 1.49B | 3.32B | 2.35B | 1.80B | 8.05B | 3.59B | 1.54B |
| Inventory | 1.81B | 1.88B | 1.93B | 2.05B | 1.74B | 2.01B | 2.18B | 2.21B |
| Total assets | 20.39B | 20.50B | 22.88B | 24.72B | 35.67B | 42.75B | 44.25B | 41.96B |
| Total current liabilities | 6.16B | 5.98B | 5.79B | 6.25B | 7.78B | 5.03B | 5.74B | 9.80B |
| Short-term debt | 1.62B | 1.44B | 1.16B | 872.00M | 2.12B | 547.00M | 690.00M | 4.94B |
| Long-term debt | 3.14B | 4.28B | 6.33B | 5.79B | 8.26B | 7.61B | 7.16B | 8.32B |
| Total liabilities | 11,400,000,000.00 | 12,224,000,000.00 | 14,435,000,000.00 | 14,792,000,000.00 | 19,356,000,000.00 | 16,148,000,000.00 | 16,737,000,000.00 | 21,666,000,000.00 |
| Total equity | 8.99B | 8.27B | 8.45B | 9.92B | 16.32B | 26.60B | 27.51B | 20.30B |
| Retained earnings | 23.07B | 24.20B | 24.96B | 26.05B | 28.05B | 40.07B | 40.83B | 40.60B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 8.63B | 9.07B | 8.58B | 8.84B | 9.25B | 9.66B |
| Cash & ST investments | 1.89B | 2.22B | 1.54B | 1.75B | 1.79B | 2.18B |
| Inventory | 2.22B | 2.29B | 2.21B | 2.35B | 2.45B | 2.51B |
| Total assets | 41.98B | 42.52B | 41.96B | 41.94B | 42.09B | 42.21B |
| Total current liabilities | 10.85B | 10.73B | 9.80B | 10.52B | 10.65B | 10.77B |
| Short-term debt | 6.19B | 6.10B | 4.94B | 5.83B | 5.95B | 5.73B |
| Long-term debt | 8.18B | 8.28B | 8.32B | 7.58B | 7.56B | 7.53B |
| Total liabilities | 22,712,000,000.00 | 22,631,000,000.00 | 21,666,000,000.00 | 21,647,000,000.00 | 21,769,000,000.00 | 21,814,000,000.00 |
| Total equity | 19.27B | 19.89B | 20.30B | 20.29B | 20.32B | 20.39B |
| Retained earnings | 39.98B | 40.27B | 40.60B | 40.87B | 41.18B | 41.58B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.89B | 3.01B | 3.08B | 3.58B | 2.92B | 637.00M | 3.33B | 3.10B |
| Depreciation & amortization | 758.00M | 822.00M | 854.00M | 762.00M | 842.00M | 1.05B | 1.69B | 1.52B |
| Free cash flow | 2.28B | 2.41B | 2.55B | 3.17B | 2.62B | 274.00M | 2.91B | 2.67B |
| Dividends paid | -1.23B | -1.21B | -1.21B | -1.21B | -1.22B | -1.20B | -1.20B | -1.19B |
| Stock buybacks / issuance | -1.00B | -1.25B | -942.00M | -500.00M | -500.00M | -2.21B | -643.00M | -1.17B |
| Ending cash balance | 1.09B | 1.49B | 3.32B | 2.35B | 1.80B | 8.05B | 3.59B | 1.54B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 241.00M | 1.07B | 1.01B | 699.00M | 779.00M | 1.42B |
| Depreciation & amortization | 384.00M | 372.00M | 379.00M | 359.00M | 369.00M | 377.00M |
| Free cash flow | 154.00M | 977.00M | 842.00M | 602.00M | 694.00M | 1.32B |
| Dividends paid | -297.00M | -297.00M | -297.00M | -312.00M | -312.00M | -311.00M |
| Stock buybacks / issuance | -223.00M | -25.00M | -20.00M | -250.00M | -292.00M | -356.00M |
| Ending cash balance | 1.89B | 2.22B | 1.54B | 1.75B | 1.79B | 2.18B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 24.94 | 26.85 | 23.62 | 25.19 | 31.92 | 85.14 | 9.30 | 10.94 |
| ROA %i | 11.02 | 11.28 | 9.06 | 9.68 | 10.70 | 33.71 | 4.52 | 5.32 |
| ROIC %i | 17.25 | 17.70 | 13.89 | 14.60 | 17.79 | 52.50 | 6.90 | 7.75 |
| 5-year avg ROE %i | 23.00 | 24.22 | 22.99 | 23.85 | 26.50 | 38.54 | 35.03 | 32.50 |
| EBIT margin %i | 16.48 | 16.66 | 14.95 | 16.88 | 21.97 | 19.70 | 13.39 | 18.43 |
| FCF / sales %i | 13.07 | 13.13 | 15.16 | 16.42 | 12.18 | 1.81 | 16.65 | 14.80 |
| Current ratioi | 1.07 | 1.19 | 1.52 | 1.35 | 1.09 | 2.75 | 1.77 | 0.88 |
| Quick ratioi | 0.67 | 0.75 | 1.06 | 0.85 | 0.52 | 2.10 | 1.13 | 0.47 |
| Debt / assetsi | 23.34 | 27.91 | 34.35 | 28.64 | 29.96 | 20.03 | 18.89 | 32.79 |
| LT debt / equityi | 35.06 | 51.95 | 79.70 | 62.79 | 82.70 | 38.74 | 35.43 | 43.51 |
| Interest coveragei | 14.20 | 15.22 | 14.34 | 18.54 | 18.92 | 11.44 | 7.25 | 8.58 |
| Revenue CAGR (3Y) %i | 2.32 | 8.15 | 3.22 | -9.43 | -9.09 | -3.33 | 10.59 | 9.28 |
| Net income CAGR (3Y) %i | -6.67 | 12.15 | 8.98 | 1.49 | 11.90 | 88.78 | -5.10 | -10.80 |
| FCF CAGR (3Y) %i | 5.44 | -0.30 | 21.02 | 11.70 | 2.83 | -52.43 | -2.79 | 0.56 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.93 | 13.05 | 10.94 | 11.35 | 12.37 | 12.81 |
| ROA %i | 5.42 | 6.02 | 5.32 | 5.47 | 5.82 | 6.08 |
| ROIC %i | 7.44 | 8.37 | 7.75 | 8.21 | 7.97 | 8.34 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.05 | 17.59 | 18.43 | 18.61 | 19.50 | 20.05 |
| FCF / sales %i | 15.69 | 15.42 | 14.80 | 14.16 | 17.01 | 18.57 |
| Current ratioi | 0.80 | 0.85 | 0.88 | 0.84 | 0.87 | 0.90 |
| Quick ratioi | 0.44 | 0.48 | 0.47 | 0.45 | 0.46 | 0.49 |
| Debt / assetsi | 35.38 | 34.97 | 32.79 | 33.19 | 33.40 | 31.40 |
| LT debt / equityi | 45.01 | 44.12 | 43.51 | 39.89 | 39.94 | 36.93 |
| Interest coveragei | 9.81 | 10.06 | 8.58 | 7.51 | 7.55 | 8.18 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Final Control is the largest reported line at 32.55% of revenue, across 5 reported segments.
- No single line clears half of revenue; Control Systems & Software is next at 24.60%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Final Control32.55%
Control Systems & Software24.60%
Sensors22.39%
Safety & Productivity11.33%
Test & Measurement9.13%
Quote time 2026-10-08 04:00:07 · For reference only, not investment advice and not tailored to your situation.